Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
McKinsey
Colorcon
Boehringer Ingelheim

Last Updated: September 26, 2022

BETOPTIC S Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Betoptic S patents expire, and what generic alternatives are available?

Betoptic S is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BETOPTIC S is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.

Drug patent expirations by year for BETOPTIC S
Drug Prices for BETOPTIC S

See drug prices for BETOPTIC S

Recent Clinical Trials for BETOPTIC S

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alcon ResearchPhase 3

See all BETOPTIC S clinical trials

Pharmacology for BETOPTIC S

US Patents and Regulatory Information for BETOPTIC S

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BETOPTIC S

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
Novartis BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for BETOPTIC S

See the table below for patents covering BETOPTIC S around the world.

Country Patent Number Title Estimated Expiration
Japan 2854418 See Plans and Pricing
Canada 2004468 GOUTTES LUBRIFIANTES A LIBERATION SOUTENUE POUR LE TRAITEMENT DU GLAUCOME (SUSTAINED RELEASE, COMFORT FORMULATION FOR GLAUCOMA THERAPY) See Plans and Pricing
Japan H09505604 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Boehringer Ingelheim
McKinsey
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.